Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cMyc oncogene (MYC) is a proto-oncogene encoding a nuclear phosphoprotein that functions as a transcription factor. It regulates cell cycle progression, cellular growth, metabolism, apoptosis, differentiation, self-renewal, and protein synthesis. Overexpression of MYC is implicated in a majority of human cancers, making it a significant therapeutic target. However, its structure poses challenges for drug development.
Inhibition of mRNA expression/translation, disruption of dimerization with Max, induction of premature degradation, blocking DNA binding activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cMyc oncogene (MYC).